Analyst consensus rating
OptimizeRx Analyst Rating: none
Direct answer
OptimizeRx's consensus rating is none.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $12.60.
Forecast evidence checked October 17, 2026.
Get free OptimizeRx email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $8.50
- Average price target
- $12.60
- High price target
- $18.00
- Low price target
- $11.00
- Low target gap
- +29.4%
- Target upside
- +48.2%
- High target gap
- +111.8%
- Target range width
- 82.4%
- Consensus rating
- none
- Analysts
- 5
- Evidence date
- October 17, 2026
- Valid through
- October 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for OptimizeRx?
OptimizeRx has a verified none consensus. The same dataset has an average price target of $12.60.
How far are OptimizeRx's low and high targets from the recorded price?
The low target implies +29.4%, while the high target implies +111.8%.
How many analysts are included in OptimizeRx's consensus?
The verified consensus includes 5 analysts.
How is OptimizeRx's target upside or downside calculated?
The average target of $12.60 is divided by the recorded price of $8.50, then one is subtracted to produce +48.2%. This does not guarantee a future return.
When was OptimizeRx's analyst forecast verified?
The data was verified on 2026-10-17. The dataset is valid through 2026-10-24.